Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes

The Journal of General Virology
Kate D RymanAlan D T Barrett

Abstract

Two monoclonal antibody neutralization resistant (MAbR) variants of the yellow fever (YF) 17D-204 vaccine virus strain were selected using YF type-specific MAb B39. These B39R variants were compared with the variant virus selected by Lobigs et al. (Virology 161, 474-478, 1987) using a second YF-type specific MAb (2E10) which mapped to amino acid position 71/72 in the envelope (E) protein. Neutralization assays with a panel of MAbs suggested that these two YF-type-specific epitopes are located in two discrete regions of the folded E protein. Each of the B39R variants had a single nucleotide mutation which encoded an amino acid substitution at either position E-155 or E-158. Thus, YF type-specific epitopes map to both domain I (B39) and II (2E10) of the YF virus E protein. The B39 defined epitope represents the first flavivirus neutralizing epitope localized to this region of domain I of the E protein.

Citations

Oct 8, 2008·Immunological Reviews·Michael S DiamondDaved H Fremont
Nov 15, 2008·The Journal of General Virology·Jody Hobson-PetersRoy A Hall
Nov 6, 2003·Virology·Renato S MarchevskyRicardo Galler
Dec 3, 2016·PLoS Neglected Tropical Diseases·Matthew T AliotaDavid H O'Connor
Oct 11, 2005·Viral Immunology·Ivan A RazumovValery B Loktev
Mar 17, 2004·Current Infectious Disease Reports·Anabelle LefeuvreVincent Deubel
Aug 25, 2005·Expert Review of Vaccines·Thomas P Monath
Jun 9, 2007·Expert Opinion on Biological Therapy·Theodore Oliphant, Michael S Diamond
Nov 5, 2019·Viral Immunology·Emily H Davis, Alan D T Barrett
Dec 28, 2002·Journal of Virology·Monica A McArthurAlan D T Barrett
Aug 24, 2018·Genes·Raphaëlle KlittingXavier de Lamballerie
Jan 19, 2002·Annals of the New York Academy of Sciences·J T RoehrigC D Blair

❮ Previous
Next ❯